Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil for Left Ventricular Strain in CTO
NCT05087797Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Apr 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicorandil in Chronic total coronary occlusion (CTO), sponsored by Peking University Third Hospital. Started Apr 2019; status: completed.
02
Drugs
nicorandil
03
Conditions
Chronic total coronary occlusion (CTO)
Beyond the preview
Go deeper on NCT05087797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087797.